Clinical Trial Update: Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD [Phase 2]

View source ↗

Summary

Phase 2 trial investigating safety and tolerability of EP395 in patients with COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• EP395

Snippet

Sponsor: EpiEndo Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease, COPD | Phase 2 | Status: COMPLETED